Acadian Asset Management LLC Buys Shares of 171,950 Haleon PLC Sponsored ADR $HLN

Key Points

• Acadian Asset Management LLC made a new investment in Haleon PLC Sponsored ADR worth approximately $1.77 million, acquiring 171,950 shares in the first quarter.
• Several institutional investors, including Allspring Global Investments and Baird Financial Group, have increased their stakes in Haleon significantly during the same quarter.
• Haleon recently declared a semi-annual dividend of $0.0555 per share, up from its previous dividend of $0.05, resulting in a dividend yield of 190.0%.

Acadian Asset Management LLC purchased a new stake in shares of Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 171,950 shares of the company's stock, valued at approximately $1,767,000.

Other institutional investors have also made changes to their positions in the company. Bartlett & CO. Wealth Management LLC boosted its stake in shares of Haleon by 135.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company's stock worth $27,000 after buying an additional 1,491 shares during the last quarter. Banque Transatlantique SA bought a new position in Haleon in the first quarter worth about $27,000. Opal Wealth Advisors LLC bought a new position in shares of Haleon during the first quarter valued at approximately $29,000. Ransom Advisory Ltd purchased a new stake in shares of Haleon during the first quarter valued at approximately $31,000. Finally, Deutsche Bank AG raised its position in Haleon by 267.8% in the first quarter. Deutsche Bank AG now owns 3,126 shares of the company's stock worth $32,000 after acquiring an additional 2,276 shares during the period. 6.67% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

HLN has been the subject of a number of recent analyst reports. The Goldman Sachs Group raised shares of Haleon from a "neutral" rating to a "buy" rating in a research note on Wednesday, September 10th. Wall Street Zen lowered shares of Haleon from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. BNP Paribas Exane upgraded shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price objective on the stock in a research report on Tuesday, May 27th. Barclays downgraded shares of Haleon from an "overweight" rating to an "equal weight" rating in a research report on Tuesday. Finally, BNP Paribas upgraded shares of Haleon to a "strong-buy" rating in a research note on Tuesday, May 27th. Two research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $12.33.

Haleon Stock Performance

NYSE HLN traded down $0.08 on Friday, hitting $9.16. 9,669,121 shares of the stock traded hands, compared to its average volume of 8,591,749. The firm has a market capitalization of $41.00 billion, a price-to-earnings ratio of 23.49, a PEG ratio of 2.73 and a beta of 0.24. Haleon PLC Sponsored ADR has a 12 month low of $8.86 and a 12 month high of $11.42. The business's fifty day moving average is $9.66 and its two-hundred day moving average is $10.17. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.63 and a current ratio of 0.87.

Haleon Increases Dividend

The business also recently declared a semi-annual dividend, which was paid on Thursday, September 18th. Investors of record on Friday, August 15th were given a $0.0555 dividend. This is an increase from Haleon's previous semi-annual dividend of $0.05. This represents a yield of 190.0%. The ex-dividend date was Friday, August 15th. Haleon's dividend payout ratio (DPR) is 28.21%.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.